Business
Vanda Pharmaceuticals Announces Participation at March 2020 Investor Conferences
WASHINGTON, Feb. 27, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced that it will participate at the following
About this update from Vanda Pharmaceuticals Inc.
[{"type":"text","content":"WASHINGTON, Feb. 27, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced that it will participate at the following upcoming investor conferences in March 2020:\nThe Cowen and Company 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020. A corporate presentation is scheduled for 8:40 a.m. Eastern Time.\nThe Barclays Global Healthcare Conference in Miami on Wednesday, March 11, 2020. A corporate presentation is scheduled for 11:45 a.m. Eastern Time.\nThe corporate presentations given at the Cowen and Barclays conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.\nAbout Vanda Pharmaceuticals Inc.\nVanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com. \nCorporate Contact: AJ Jones II Chief Corporate Affairs and Communications Officer Vanda Pharmaceuticals Inc. 202-734-3400 [email protected] \nElizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. 202-734-3400 [email protected] \n View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-march-2020-investor-conferences-301013064.html\nSOURCE Vanda Pharmaceuticals Inc.","length":3319,"tagName":"div"}]